Vivos Therapeutics Statistics

Total Valuation

VVOS has a market cap or net worth of $13.77 million. The enterprise value is $9.10 million.

Market Cap	13.77M
Enterprise Value	9.10M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

VVOS has 4.77 million shares outstanding. The number of shares has increased by 210.69% in one year.

Current Share Class	4.77M
Shares Outstanding	4.77M
Shares Change (YoY)	+210.69%
Shares Change (QoQ)	+104.91%
Owned by Insiders (%)	1.54%
Owned by Institutions (%)	5.27%
Float	4.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.71
Forward PS	0.79
PB Ratio	1.80
P/TBV Ratio	3.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.21.

Current Ratio	1.44
Quick Ratio	1.32
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -325.98% and return on invested capital (ROIC) is -136.35%.

Return on Equity (ROE)	-325.98%
Return on Assets (ROA)	-60.87%
Return on Capital (ROIC)	-136.35%
Revenue Per Employee	$118,545
Profits Per Employee	-$102,179
Employee Count	123
Asset Turnover	1.14
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.47% in the last 52 weeks. The beta is 7.68, so VVOS's price volatility has been higher than the market average.

Beta (5Y)	7.68
52-Week Price Change	-28.47%
50-Day Moving Average	2.78
200-Day Moving Average	2.99
Relative Strength Index (RSI)	52.35
Average Volume (20 Days)	164,116

Short Selling Information

The latest short interest is 95,088, so 2.00% of the outstanding shares have been sold short.

Short Interest	95,088
Short Previous Month	69,756
Short % of Shares Out	2.00%
Short % of Float	2.22%
Short Ratio (days to cover)	0.66

Income Statement

In the last 12 months, VVOS had revenue of $14.58 million and -$12.57 million in losses. Loss per share was -$3.52.

Revenue	14.58M
Gross Profit	9.01M
Operating Income	-12.50M
Pretax Income	-15.64M
Net Income	-12.57M
EBITDA	-11.91M
EBIT	-12.50M
Loss Per Share	-$3.52

Full Income Statement

Balance Sheet

The company has $6.31 million in cash and $1.64 million in debt, giving a net cash position of $4.67 million or $0.98 per share.

Cash & Cash Equivalents	6.31M
Total Debt	1.64M
Net Cash	4.67M
Net Cash Per Share	$0.98
Equity (Book Value)	7.67M
Book Value Per Share	1.61
Working Capital	2.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.50 million and capital expenditures -$568,000, giving a free cash flow of -$13.07 million.

Operating Cash Flow	-12.50M
Capital Expenditures	-568,000
Free Cash Flow	-13.07M
FCF Per Share	-$2.74

Full Cash Flow Statement

Margins

Gross margin is 61.80%, with operating and profit margins of -85.71% and -86.19%.

Gross Margin	61.80%
Operating Margin	-85.71%
Pretax Margin	-86.19%
Profit Margin	-86.19%
EBITDA Margin	-81.70%
EBIT Margin	-85.71%
FCF Margin	-87.09%

Dividends & Yields

VVOS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-210.69%
Shareholder Yield	-210.69%
Earnings Yield	-91.26%
FCF Yield	-94.88%

Analyst Forecast

The average price target for VVOS is $6.30, which is 117.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.30
Price Target Difference	117.99%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 27, 2023. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Oct 27, 2023
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	4